Medpace Holdings, Inc. (MEDP) Stock Forecast
MEDP analyst forecast
as of October 18, 2026- Analyst consensus
- Hold 3.07 / 5 from 14 analysts
- Price target
- $595.92 average of analyst targets
- Upside to target
- −3.6% from the latest close
- Next earnings
- October 21, 2026 EPS estimate $4.45
- 52-week range
- $393.42 – $630.19
MEDP analyst ratings
14 analystsNumber of analysts at each rating.
MEDP price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
MEDP earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $4.46 | $4.31 | $4.69 | $3.86 | +15.6% | 8 |
| Current fiscal year (2026) | $17.72 | $17.50 | $18.37 | $15.28 | +15.9% | 10 |
| Next fiscal year (2027) | $19.32 | $17.60 | $20.16 | $17.72 | +9.0% | 10 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
MEDP revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $714.4M | $706.1M | $736.3M | +8.3% | 11 |
| Current fiscal year (2026) | $2.85B | $2.83B | $2.89B | +12.7% | 13 |
| Next fiscal year (2027) | $3.03B | $2.92B | $3.20B | +6.3% | 13 |
MEDP EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
MEDP revenue: reported and forecast
MEDP EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $4.30 | $4.44 | $4.44 | $4.46 | $4.46 | +3.7% | 1 up · 0 down |
| Current fiscal year (2026) | $17.17 | $17.70 | $17.70 | $17.72 | $17.72 | +3.2% | 2 up · 0 down |
| Next fiscal year (2027) | $18.75 | $19.31 | $19.31 | $19.32 | $19.32 | +3.0% | 1 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
MEDP earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; MEDP beat in 12 of 12.
What analysts expect from MEDP
14 analysts cover Medpace; their consensus rating is hold (3.07 on a 1–5 scale, where 5 is a strong buy). The average price target is $595.92, 3.6% below the latest close of $618.47. Analysts expect earnings of $17.72 per share for 2026, +15.9% from a year earlier. For 2027 the average estimate is $19.32 per share on revenue of $3.0 billion. Medpace beat the EPS estimate in 12 of the last 12 quarters.
Related: MEDP income statement, MEDP key metrics, MEDP chart. See the MEDP stock overview for the latest quote and news.
MEDP forecast FAQ
What is Medpace's price target?
The average analyst price target for Medpace is $595.92, 3.6% below the latest close of $618.47.
Is Medpace a buy, hold or sell?
Of 14 analysts covering Medpace, 1 rate it a strong buy, 1 a buy, 11 a hold, 0 a sell and 1 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.
What is Medpace's EPS forecast?
Analysts forecast $17.72 per share for 2026 (range $17.50 to $18.37); for 2027 the estimate is $19.32.
What is Medpace's revenue forecast?
The average revenue estimate for 2026 is $2.9 billion, growth of 12.7%; for 2027 it is $3.0 billion.
When does Medpace report earnings?
Medpace is expected to report results for the quarter ending September 30, 2026 on October 21, 2026 after the market closes; the EPS estimate is $4.45.
Does Medpace usually beat earnings estimates?
Medpace reported EPS at or above the analyst estimate in 12 of the last 12 quarters.